Actionable insights straight to your inbox

Equities logo

3 Rules Biotech Investors Need to Live By

Excellent diligence doesn't always mean you'll be saved from a nasty surprise. The nature of investing in biotech means assuming the risk that a therapeutic development program may fail.
Amarin Pharmaceuticals (AMRN) took another hit Wednesday during a year that’s been a rough one for the company as a whole. Amarin was off over 14 percent in trading on Wednesday after the
Reversing an earlier US district court decision on Sept. 12, a US appeals court ruled both Teva Pharmaceutical Industries Ltd. (TEVA) and Par Pharmaceuticals could go ahead with plans to market a